Resona Asset Management Co. Ltd. Buys 22,595 Shares of Danaher Corporation $DHR

Resona Asset Management Co. Ltd. raised its stake in Danaher Corporation (NYSE:DHR) by 4.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 513,288 shares of the conglomerate’s stock after purchasing an additional 22,595 shares during the period. Resona Asset Management Co. Ltd. owned approximately 0.07% of Danaher worth $100,071,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. UniSuper Management Pty Ltd raised its position in shares of Danaher by 10.8% during the third quarter. UniSuper Management Pty Ltd now owns 170,291 shares of the conglomerate’s stock valued at $33,762,000 after buying an additional 16,659 shares during the last quarter. Westfuller Advisors LLC acquired a new stake in Danaher during the third quarter worth about $291,000. Lockheed Martin Investment Management Co. increased its stake in Danaher by 49.4% during the third quarter. Lockheed Martin Investment Management Co. now owns 25,340 shares of the conglomerate’s stock valued at $5,024,000 after acquiring an additional 8,380 shares during the period. Hudson Value Partners LLC increased its stake in Danaher by 43.3% during the third quarter. Hudson Value Partners LLC now owns 5,210 shares of the conglomerate’s stock valued at $1,033,000 after acquiring an additional 1,575 shares during the period. Finally, Parkside Financial Bank & Trust raised its holdings in Danaher by 9.4% in the 3rd quarter. Parkside Financial Bank & Trust now owns 4,052 shares of the conglomerate’s stock valued at $803,000 after acquiring an additional 348 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Activity

In other Danaher news, Director Teri List sold 3,298 shares of Danaher stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the transaction, the director owned 20,762 shares in the company, valued at approximately $4,702,593. The trade was a 13.71% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Brian W. Ellis sold 21,776 shares of the stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the sale, the senior vice president owned 14,553 shares in the company, valued at $3,190,454.19. The trade was a 59.94% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 30,248 shares of company stock worth $6,609,663. Insiders own 11.10% of the company’s stock.

Danaher Stock Performance

Danaher stock opened at $234.91 on Friday. The firm has a market capitalization of $165.93 billion, a P/E ratio of 48.43, a P/E/G ratio of 3.65 and a beta of 0.89. The stock has a fifty day moving average price of $230.26 and a two-hundred day moving average price of $213.09. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $258.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10.

Danaher (NYSE:DHR) last posted its earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.17. The business had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.71 EPS. As a group, analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Friday, December 26th. Danaher’s dividend payout ratio is currently 26.39%.

Analysts Set New Price Targets

Several analysts have recently weighed in on the company. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a report on Monday, December 29th. Deutsche Bank Aktiengesellschaft raised their target price on Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Leerink Partners lifted their price target on shares of Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. Robert W. Baird set a $247.00 price objective on shares of Danaher in a research note on Wednesday, October 22nd. Finally, Guggenheim raised their price objective on shares of Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a report on Friday, January 2nd. Twenty investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and an average price target of $252.09.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.